Nuzenio

Catalent

Catalent news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 7 latest news signals 7 publisher sources 100/100 entity strength

Latest news

Scholar Rock drops Catalent facility from marketing application for muscle weakness drug - 1470 & 100.3 WMBD1470 & 100.3 WMBD · Sat, 08 Aug 2026 02:32:33 GMTCodis Completes Acquisition of Catalent's Nottingham, UK Facility, Expanding Europe's Premier Spray Dry Network - PR NewswirePR Newswire · Mon, 03 Aug 2026 16:12:00 GMTTaysha Taps Catalent for Potential Commercial Manufacturing of TSHA-102 - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 13:16:10 GMTCodis Completes Acquisition of Catalent’s Nottingham, UK Facility - Contract PharmaContract Pharma · Mon, 03 Aug 2026 13:06:21 GMTTaysha Gene Therapies and Catalent Expand Strategic - GlobeNewswireGlobeNewswire · Mon, 03 Aug 2026 12:00:00 GMTTaysha Gene Therapies, Inc. and Catalent, Inc. Expand Strategic Partnership to Include Future Commercial Manufacturing Support of TSHA-102 Gene Therapy for Rett Syndrome - marketscreener.commarketscreener.com · Mon, 03 Aug 2026 12:00:00 GMTTaysha and Catalent partner for commercial manu... - pluang.compluang.com · Mon, 03 Aug 2026 07:00:00 GMT

Timeline

Sat, 08 Aug 2026 02:32:33 GMTScholar Rock drops Catalent facility from marketing application for muscle weakness drug - 1470 & 100.3 WMBD
Mon, 03 Aug 2026 16:12:00 GMTCodis Completes Acquisition of Catalent's Nottingham, UK Facility, Expanding Europe's Premier Spray Dry Network - PR Newswire
Mon, 03 Aug 2026 13:16:10 GMTTaysha Taps Catalent for Potential Commercial Manufacturing of TSHA-102 - Yahoo Finance
Mon, 03 Aug 2026 13:06:21 GMTCodis Completes Acquisition of Catalent’s Nottingham, UK Facility - Contract Pharma
Mon, 03 Aug 2026 12:00:00 GMTTaysha Gene Therapies and Catalent Expand Strategic - GlobeNewswire
Mon, 03 Aug 2026 12:00:00 GMTTaysha Gene Therapies, Inc. and Catalent, Inc. Expand Strategic Partnership to Include Future Commercial Manufacturing Support of TSHA-102 Gene Therapy for Rett Syndrome - marketscreener.com

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Catalent.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

7 distinct publisher/source names are currently connected to this entity page.